Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline pharmaceutical sdn. bhd. - zanamivir -

Malta - English - Malta Medicines Authority

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - zanamivir - inhalation powder, pre-dispensed - zanamivir 5 µg/dose - antivirals for systemic use

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

glaxo wellcome production - zanamivir - powder for inhalation - 5mg

Singapore - English - HSA (Health Sciences Authority)

roche singapore pte. ltd. - oseltamivir phosphate 39.4mg equivalent to oseltamivir - capsule - 30mg - oseltamivir phosphate 39.4mg equivalent to oseltamivir 30mg

Singapore - English - HSA (Health Sciences Authority)

roche singapore pte. ltd. - oseltamivir phosphate 59.10 mg equivalent to oseltamivir - capsule - 45mg - oseltamivir phosphate 59.10 mg equivalent to oseltamivir 45mg

Singapore - English - HSA (Health Sciences Authority)

roche singapore pte. ltd. - oseltamivir phosphate 98.5 mg eqv oseltamivir - capsule - 75 mg - oseltamivir phosphate 98.5 mg eqv oseltamivir 75 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

ultra health medical pty ltd - 57793 - public respirator, single-use - a filtering mask [n95 (filter efficiency 95%)] designed to be placed over the nose and mouth of a member of the general public to permit normal breathing while protecting the wearer from exposure to pathogenic biological airborne particulates during a public health medical emergency (e.g., influenza pandemic). it is typically made of multiple layers of non-woven polymers, and incorporates a forming nosepiece (metal wire); it is typically secured using elastic head straps. this is a single-use device.

United States - English - NLM (National Library of Medicine)

amneal pharmaceuticals of new york llc - rimantadine hydrochloride (unii: jei07oos8y) (rimantadine - unii:0t2ef4jqtu) - rimantadine hydrochloride 100 mg - rimantadine hydrochloride tablet is indicated for the prophylaxis and treatment of illness caused by various strains of influenza a virus in adults (17 years and older). rimantadine hydrochloride tablet is indicated for prophylaxis against influenza a virus in children (1 year to 16 years of age). in controlled studies of children (1 year to 16 years of age), healthy adults (17 years and older), and elderly patients (65 years of age and older), rimantadine hydrochloride has been shown to be safe and effective in preventing signs and symptoms of infection caused by various strains of influenza a virus. since rimantadine hydrochloride does not completely prevent the host immune response to influenza a infection, individuals who take this drug may still develop immune responses to natural disease or vaccination and may be protected when later exposed to antigenically-related viruses. following vaccination during an influenza outbreak, rimantadine hydrochloride prophylaxis should be considered for the 2 to 4 week time period required to develop an antibody response. however, the safety and effectiveness of rimantadine hydrochloride prophylaxis have not been demonstrated for longer than 6 weeks. rimantadine hydrochloride therapy should be considered for adults (17 years and older) who develop an influenza-like illness during known or suspected influenza a infection in the community. when administered within 48 hours after onset of signs and symptoms of infection caused by influenza a virus strains, rimantadine hydrochloride has been shown to reduce the duration of fever and systemic symptoms. the following points should be considered before initiating treatment or prophylaxis with rimantadine hydrochloride: - rimantadine hydrochloride is not a substitute for early vaccination on an annual basis as recommended by the centers for disease control and prevention advisory committee on immunization practices. - influenza viruses change over time. emergence of resistance mutations could decrease drug effectiveness. other factors (for example, changes in viral virulence) might also diminish clinical benefit of antiviral drugs. prescribers should consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use rimantadine hydrochloride. rimantadine hydrochloride tablet is contraindicated in patients with known hypersensitivity to drugs of the adamantane class, including rimantadine and amantadine.

United States - English - NLM (National Library of Medicine)

caraco pharma, inc. - rimantadine hydrochloride (unii: jei07oos8y) (rimantadine - unii:0t2ef4jqtu) - rimantadine hydrochloride 100 mg - flumadine is indicated for the prophylaxis and treatment of illness caused by various strains of influenza a virus in adults (17 years and older). flumadine is indicated for prophylaxis against influenza a virus in children (1 year to 16 years of age). prophylaxis: in controlled studies of children (1 year to 16 years of age), healthy adults (17 years and older), and elderly patients (65 yeas of age and older), flumadine has been shown to be safe and effective in preventing signs and symptoms of infection caused by various strains of influenza a virus. since flumadine does not completely prevent the host immune response to influenza a infection, individuals who take this drug may still develop immune responses to natural disease or vaccination and may be protected when later exposed to antigenically-related viruses. following vaccination during an influenza outbreak, flumadine prophylaxis should be considered for the 2 to 4 week time period required to develop an antibody response. however, the safety and ef

United States - English - NLM (National Library of Medicine)

physician therapeutics llc - rimantadine hydrochloride (unii: jei07oos8y) (rimantadine - unii:0t2ef4jqtu) - rimantadine hydrochloride 100 mg - indications and usage rimantadine hydrochloride tablet is indicated for the prophylaxis and treatment of illness caused by various strains of influenza a virus in adults (17 years and older). rimantadine hydrochloride tablet is indicated for prophylaxis against influenza a virus in children (1 year to 16 years of age). prophylaxis in controlled studies of children (1 year to 16 years of age), healthy adults (17 years and older), and elderly patients (65 years of age and older), rimantadine hydrochloride has been shown to be safe and effective in preventing signs and symptoms of infection caused by various strains of influenza a virus. since rimantadine hydrochloride does not completely prevent the host immune response to influenza a infection, individuals who take this drug may still develop immune responses to natural disease or vaccination and may be protected when later exposed to antigenically-related viruses. following vaccination during an influenza outbreak, rimantadine hydrochloride